Alto Neuroscience secures $120M to advance novel depression therapy ALTO-207 through Phase 3 trials, aiming for FDA ...
SB Nation on MSN
Baseball: Northwestern walks off USC to claim first Big Ten win
Logan de Groot plays hero for the ‘Cats as they topple the ranked Trojans ...
Alto Neuroscience, Inc. ("Alto") (NYSE: ANRO), a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, announced today that ...
Ferry passengers may soon face higher fares and fewer trips as the maritime industry grapples with surging global oil prices, the Maritime Industry ...
"I think that the new leadership under Mojtaba might be willing to take more risks," a former Israeli official told Newsweek.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results